Skip to main navigation
X4 Pharmaceuticals
  • About
  • our medicine
  • science & pipeline
  • Patients
  • healthcare professionals
  • Investors
    • Company Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Governance
    • SEC Filings
    • Investor FAQs
  • Careers
X4 Pharmaceuticals X4 Pharmaceuticals
  • About
  • our medicine
  • science & pipeline
  • Patients
  • healthcare professionals
  • Investors
    • Company Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Analyst Coverage
    • Governance
    • SEC Filings
    • Investor FAQs
  • Careers

Events & Presentations

Corporate Presentation
X4 Pharmaceuticals April 2026 Corporate Presentation
Upcoming Events
There are no upcoming events available at this time.
Past Events
Mar 11, 2026 at 10:00 AM EDT
Leerink Global Healthcare Conference
Click here for webcast
Feb 12, 2026 at 12:30 PM EST
Guggenheim Emerging Outlook: Biotech Summit 2026
Click here for webcast
Nov 10, 2025 at 8:30 AM EST
Guggenheim Second Annual Healthcare Innovation Conference
Click here for webcast
Other Presentations
EHA 2025: Mavorixafor, an Oral CXCR4 Antagonist, Allows for Granulocyte-Colony Stimulating Factor Dose De-Escalation in Phase 2 Trial Participants with Primary Chronic Neutropenia
2026-06
EHA 2025: Evaluating the Safety and Efficacy of Mavorixafor, an Oral CXCR4 Antagonist, in Participants with Primary Chronic Neutropenic Disorders: Results from the Phase 2 Study
2026-06
XOLREMDI™ (mavorixafor) FDA Approval Conference Call and Webcast Presentation
2024-04
ASH 2023: Mavorixafor for Patients with Chronic Neutropenic Disorders Treated with G-CSF
2023-12
X4 Pharmaceuticals 4WHIM Phase 3 Clinical Data Virtual Investor Event Presentation
2023-05
4WHIM Phase 3 Top-Line Results
2022-11
Chronic Neutropenia Phase 1b Results
2022-09
Waldenström’s Macroglobulinemia Phase 1b Results
2022-08
ASH 2021: X4 Understanding Primary Immunodeficiencies Event
2021-12
ASH 2021: X4 Supplemental Waldenström’s Macroglobulinemia Slides
2021-12

quick links

Quick Links

  • About
  • Patients
  • Investors
  • Careers
footer logo

contact

X4 Pharmaceuticals
61 North Beacon Street
4th Floor
Boston, MA 02134 Phone: 857.529.8300
© 2026 X4 Pharmaceuticals, Inc. All rights reserved.  

Live - Footer

Terms of Use | Privacy | Compliance and Ethics